|Last Price$23.02||Day Change (%)0.22%|
|Open Price$23.08||Day Change ($)0.05|
|Day Range22.92–23.10||52-Week Range16.81–23.10|
As of Fri 12/26/2014 04:37 PM EST | USD
CEL- SCI Expands Its Pivotal Phase III Immunotherapy Head and Neck Cancer Trial With Addition of 7 More Clinical Sites
Paramount Pictures and Warner Bros. Pictures’ “INTERSTELLAR” Crosses $100 Million Milestone in IMAX® Theatres Around the Globe
More Than 150 Companies Expected to Present at the 17th Annual BIO CEO & Investor Conference
Research and Markets: Global Wearable Technologies Report 2014 - The Sun in the IoT Galaxy
Nektar Presents Data on Target-Specific Biomarkers from Circulating Tumor Cell Sub-Study of Phase 3 BEACON Study of Etirinotecan Pegol (NKTR-102) in Patients with Advanced Breast Cancer
Research and Markets: Myocarditis - Pipeline Review, H2 2014
Two stock funds that trailed most of their peers in 2008 have beaten most of them in the recent sell-off.
Longer life expectancies, unfavorable secular trends toward cremations, and intense price competition are hampering longer-term growth and profitability.
Sanmina- SCI SANM provided an update on its second-quarter financial performance Monday. Management said demand in the communications and enterprise computing sectors has been weaker than expected, and it lowered its second-quarter revenue forecast to $2.6 billion from $2.65-$2.75 billion. It will ...